Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Tuesday, August 5, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Zscaler Completes Acquisition of Red Canary for Agentic AI-driven Security Operations
Palantir Secures $10B AI Contract with U.S. Army
Augmodo Raises $37.5M to Modernize and Grow Spatial AI Tech
Joby Collaborates with L3Harris to Pursue Defense Applications for Autonomous Hybrid…
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
Virotherapies
virotherapies
Biotechnology
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
News Desk
-
April 11, 2025
Calidi Biotherapeutics, a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, announced the appointment of Guy Travis Clifton, MD as Chief...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Zscaler Completes Acquisition of Red Canary for Agentic AI-driven Security Operations
Palantir Secures $10B AI Contract with U.S. Army
Augmodo Raises $37.5M to Modernize and Grow Spatial AI Tech
Load more
